Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: Results from the BRAVO and CRUISE trials

Ophthalmology

Volumn 119, Issue 10, 2012, Pages 2108-2118

  Varma, Rohit ^a   Bressler, Neil M ^b   Suñer, Ivan ^c   Lee, Paul ^d   Dolan, Chantal M ^e   Ward, James ^e   Colman, Shoshana ^e   Rubio, Roman G ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Retina Associates of Florida   (United States)

^d DUKE UNIVERSITY EYE CENTER   (United States)

^e GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; SHAM PROCEDURE; TREATMENT DURATION; VISION;

ACTIVITIES OF DAILY LIVING; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; QUESTIONNAIRES; RETINAL VEIN OCCLUSION; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84867100215     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.05.017     Document Type: Article

References (31)

1. R. Klein, B.E. Klein, S.E. Moss, S.M. Meuer The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study Trans Am Ophthalmol Soc 98 2000 133 141 discussion 141-3
2. J. Rehak, M. Rehak Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities Curr Eye Res 33 2008 111 131
3. P. Mitchell, W. Smith, A. Chang Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study Arch Ophthalmol 114 1996 1243 1247
4. M. Rehak, P. Wiedemann Retinal vein thrombosis: pathogenesis and management J Thromb Haemost 8 2010 1886 1894
5. Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 1984 271 282
6. D. Prisco, R. Marcucci Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach Pathophysiol Haemost Thromb 32 2002 308 311
7. P.A. Campochiaro Anti-vascular endothelial growth factor treatment for retinal vein occlusions Ophthalmologica 227 2012 30 35
8. N.J. London, G. Brown Update and review of central retinal vein occlusion Curr Opin Ophthalmol 22 2011 159 165
9. P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
10. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
11. P.A. Campochiaro, D.M. Brown, C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
12. D.M. Brown, P.A. Campochiaro, R. Bhisitkul Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 1594 1602
13. C.M. Mangione, P.P. Lee, P.R. Gutierrez National Eye Institute Visual Function Questionnaire Field Test Investigators Development of the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 119 2001 1050 1058
14. C.M. Mangione, P.P. Lee, J. Pitts NEI-VFQ Field Test Investigators Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ) Arch Ophthalmol 116 1998 1496 1504
15. National Eye Institute National Eye Institute Visual Functioning Questionnaire-25 (VFQ-25) Version 2000 http://www.nei.nih.gov/resources/ visionfunction/vfq-ia.pdf Accessed May 1, 2012
16. C.M. Mangione The National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) 2000 National Eye Institute Bethesda, MD http://www.nei.nih.gov/resources/visionfunction/manual-cm2000.pdf Accessed May 1, 2012
17. M.T. Cahill, S.S. Stinnett, A.D. Banks Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration Ophthalmology 112 2005 144 151
18. P.H. Miskala, N.M. Bressler, C.L. Meinert Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration Arch Ophthalmol 122 2004 758 766
19. Submacular Surgery Trials Research Group Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization - SST report no. 1 Arch Ophthalmol 121 2003 531 539
20. Age-Related Eye Disease Study Research Group Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14 Arch Ophthalmol 123 2005 1207 1214
21. Submacular Surgery Trials Research Group Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST report number 19 Ophthalmic Epidemiol 14 2007 205 215
22. S.P. Azen, R. Varma, S. Preston-Martin Los Angeles Latino Eye Study Group Binocular visual acuity summation and inhibition in an ocular epidemiological study: the Los Angeles Latino Eye Study Invest Ophthalmol Vis Sci 43 2002 1742 1748
23. N.M. Bressler, T.S. Chang, I.J. Suner MARINA Research Group, ANCHOR Research Group Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR Ophthalmology 117 2010 747 756
24. G.H. Berdeaux, J.P. Nordmann, E. Colin, B. Arnould Vision-related quality of life in patients suffering from age-related macular degeneration Am J Ophthalmol 139 2005 271 279
25. A.M. Damiano, E.P. Steinberg, S.D. Cassard Comparison of generic versus disease-specific measures of functional impairment in patients with cataract Med Care 33 1995 AS120 AS130
26. S. Datta, A.J. Foss, M.J. Grainge The importance of acuity, stereopsis, and contrast sensitivity for health-related quality of life in elderly women with cataracts Invest Ophthalmol Vis Sci 49 2008 1 6
27. P. Desai, A. Reidy, D.C. Minassian Gains from cataract surgery: visual function and quality of life Br J Ophthalmol 80 1996 868 873
28. D.B. Elliott, A.E. Patla, M. Furniss, A. Adkin Improvements in clinical and functional vision and quality of life after second eye cataract surgery Optom Vis Sci 77 2000 13 24
29. V.K. Gothwal, T.A. Wright, E.L. Lamoureux Improvements in visual ability with first-eye, second-eye, and bilateral cataract surgery measured with the visual symptoms and quality of life questionnaire J Cataract Refract Surg 37 2011 1208 1216
30. R.H. Harwood, A.J. Foss, F. Osborn Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial Br J Ophthalmol 89 2005 53 59
31. E.P. Steinberg, J.M. Tielsch, O.D. Schein National study of cataract surgery outcomes: variation in 4-month postoperative outcomes as reflected in multiple outcome measures Ophthalmology 101 1994 1131 1140 discussion 1140-1